Molecular Diagnosis and Identification of Leishmania Species in Jordan from Saved Dry Samples

Abstract EN

Diagnosis of the endemic cutaneous leishmaniasis (CL) in Jordan relies on patient clinical presentation and microscopic identification.

Studies toward improved identification of the causative Leishmania species, especially in regions where multiple species exist, and the introduction of these techniques into medical diagnosis is paramount.

This study looked at the current epidemiology of CL in Jordan.

Clinically diagnosed 41 patients with CL were tested for the presence of Leishmania parasite using both Giemsa staining from skin scraps on glass slides and ITS1-PCR from samples blotted onto storage cards (NucleoCards®).

Microscopically, 28 out of the 41 (68.3%) collected samples were positive for amastigotes, whereas the molecular ITS1-PCR amplification successfully identified 30 of the 41 samples (73.2%).

Furthermore, PCR-RFLP analysis allowed species identification which is impossible microscopically.

Of the 30 PCR positive samples, 28 were Leishmania major positive and the other two samples were Leishmania tropica.

This indicates that L.

major is the most prevalent species in Jordan and the two L.

tropica cases originated from Syria indicating possible future L.

tropica outbreaks.

Diagnosis of CL based on clinical presentation only may falsely increase its prevalence.

Although PCR is more sensitive, it is still not available in our medical laboratories in Jordan.